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Summary 
Class II-mediated signals play potential roles in B cell 
activation and antigen presentation. The regions of 
the class II molecule participating in B cell signaling 
are incompletely defined. Our prior analysis of struc- 
tural requirements of the cytoplasmic domain of AB 
revealed that only the eight membrane-proximal resi- 
dues are required for signaling. Here, we report that 
the sequence and position of two of these are critical, 
and present direct evidence that the AB transmem- 
brane domain is also involved in signaling, via a path- 
way distinct from the cytoplasmic domain. These re- 
sults demonstrate that specific regions in both the 
cytoplasmic and transmembrane domains of the class 
II molecule have distinct signaling functions. 
Introduction 
Major histocompatibility complex (MHC) class II molecules 
are expressed constitutively on B cells, monocytes, mac- 
rophages, and dendritic cells, and can be induced in other 
cell types following various activation signals. In T cell-B 
cell interactions, MHC class II serves to present peptide 
antigen to T helper (Th) cells and to deliver activation sig- 
nals to the B cell. Involvement of MHC class II-mediated 
signals in B cell homotypic adhesion (Kansas and Tedder, 
1991; Kansas et al., 1992) antigen presentation (Nabavi 
et al., 1989, 1992; St. Pierre and Watts, 1991) rescue 
from anergy (Bishop et al., 1993, 1994) and proliferation 
and differentiation (Palacios et al., 1983; Bishop and 
Haughton, 1986; Baluyut and Subbarao, 1988; Cambier 
and Lehmann, 1989; Takahama et al., 1989; Hamano et 
al., 1990; Lane et al., 1990) has been demonstrated for 
both mouse and human B cells. Class II-induced in- 
creases in intracellular calcium, inositol phosphate turn- 
over, and protein tyrosine kinase (PTK) activation have 
been demonstrated in human B cells (Lane et al., 1990; 
Mooney et al., 1990). In mouse B cells, CAMP generation 
is seen following MHC class II engagement and has been 
implicated in many of the processes attributed to MHC 
class II signaling (Wade et al., 1989; Bishop, 1991; St. 
Pierre and Watts, 1991; Fuleihan et al., 1992; Nabavi et 
al., 1992; Newell et al., 1993). A role for aserinelthreonine 
kinase that translocates following MHC class II signaling 
has also been suggested (Cambier et al., 1987; Wade 
et al., 1989). Recently, evidence has been presented for 
elevation of intracellular calcium and PTK activation when 
MHC class II is cross-linked on a mouse B lymphoma, K46 
(Andre et al., 1994) and we have confirmed this observa- 
tion using normal splenic B cells (M. Baccam and G. A. B., 
unpublished data). Both we and others have also reported 
class II-mediated activation of proliferation of normal 
mouse splenic B cells (Baluyut and Subbarao, 1988; Cam- 
bier and Lehmann, 1989; Bishop et al., 1994). 
Structure-function studiesof MHC class II have demon- 
strated the importance of the cytoplasmic (CY) domain in 
various class II-mediated signals. These include nuclear 
translocation of a cytoplasmic CAMP-dependent kinase 
(Wade et al., 1989), and antigen presentation to a subset 
of Th cell hybridomas (Nabavi et al., 1989; St. Pierre and 
Watts, 1991). Our analyses of the mouse B cell clone 
CH12.LX indicate that only the eight membrane-proximal 
residues of the CY domain of the AB chain are necessary 
for induction of class II-mediated antigen-dependent im- 
munoglobulin M (IgM) secretion. Specific residues within 
this minimal CY domain are important to signaling, but 
complete removal of the A0 CY domain does not totally 
abrogate class II-mediated B cell activation (Harton and 
Bishop, 1993). Together with the recent report that class 
II molecules lacking CY domains are still capable of stimu- 
lating PTK activity in the K46 B cell line (Andre et al., 1994) 
these data suggest that other domains of the class II mole- 
cule also contribute to B cell signaling. The present report 
demonstrates that just two position-dependent amino 
acids in the A0 CY domains are critical to the contribution 
the CY domain makes to class II signaling, and that this 
contribution correlates directly with induction of elevated 
intracellular CAMP. Evidence is also presented that the 
transmembrane (TM) domain of Ar plays an essential role 
in class II signaling, similar in importance to that of the 
CY domain signal. However, signals delivered via the TM 
domain do not involve elevation of CAMP, and evidence 
is presented that the TM domain signals via a pathway 
distinct from that of the CY domain. 
Results 
Glycine 227 and Proline 228 Play a Dominant 
Sequence- and Position-Dependent Role 
in Class II-Mediated Signaling 
In experiments examining signaling through A molecules 
with truncated 8 chains, we recently demonstrated that 
only the eight most membrane-proximal residues of the 
CY domain (amino acids 220-228; Figure 1 A) are required 
for optimal levels of signal transduction (Harton and 
Bishop, 1993). Removal of proline (P) 228 or both glycine 
(G) 227 and proline 228 led to substantial decreases in 
class II signaling (mutants ABBAll and ABBA12, respec- 
tively; Harton and Bishop, 1993; Figure 1A). A construct 
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Figure 1. Structure of A$ Molecules with CY and TM Domain Muta- 
tions 
(A) Amino acid sequence of CY domain truncation and replacement 
mutants and summary of signaling results for each group of transfec- 
tan&. Ratio of signaling via AW (%) was calculated as described in 
Experimental Procedures. No 6CT3 mutant is listed because transfec- 
tants did not express 6CT3 (RAAAGPAA) at acceptable levels for 
analysis. 
(B) Schematic of the ArTMa molecule. The molecule has a wild-type 
CY domain, and the 6 chain TM domain has been replaced with that 
of A. Summary ratio of signaling via the transfectants expressing the 
ArTM. molecule versus wild-type endogenous class II is given at right. 
replacing the minimal length cytoplasmic tail with a single 
arginine followed by 7 alanines @CT1 , Figure 1A) is inca- 
pable of restoring signaling, demonstrating that specific 
residues within the minimal CY domain are required (Har- 
ton and Bishop, 1993). 
Because removal of G227 and P228 has such a pro- 
found effect on class II signaling, in the present study they 
were restored to their wild-type positions individually or 
together, or replaced in different positions in replacement 
CY domains similar to f3CTl. The sequence of each of 
these replacement mutants is shown in Figure 1A. As is 
the case for all mutants analyzed (see Harton and Bishop, 
1993) each of the PCT replacement mutants analyzed 
was expressed on the surface of individual transfectants 
of CHlP.LX at levels equal to or greater than transfected 
wild-type hb (data not shown). Although there is variation 
between subclones of a given transfectant in the degree 
of signaling through a single class II molecule, the ratio 
of signaling via a transfected molecule as a percentage of 
signaling through wild-type class II is a consistent measure 
of signal transduction. This is illustrated in Harton and 
2 250,000 - 
L? 
~ 200.000- 
9 
;; 150.000- 
Li 
100,000 - 
ABB4 BCT61 BCT62 BCT67 
Trawfectant tested 
Y 
Y 
* 
Q 06- 
,0 
a 
03- 
oo- 
Nt ECTI DCT2 BCT4 OCT5 DCT6 8CT7 None 
J 
AB molecule expressed 
Figure2. Class II-Mediated Signaling in Subclones of CHlP.LX- 
Expressing ArQ CY Replacement Mutants 
(A) Example of how relative signaling is determined for each mutant 
bb molecule produced. CHlP.LX, the subclone ABB4 (expressing 
wild-type A& and the subclones 6CT6.1, pCT6.2, and 5CT6.7 (ex- 
pressing the 6CT6 mutant) were stimulated as described above. The 
number of pfc/lO’viable cells was determined as described in Experi- 
mental Procedures. pfc values of control cultures (no stimulus) were 
subtracted from the values shown; control values were 52000 pfcl 
IO8 cells. Numbers above bars for each clone represent the ratio of 
the pfc values for cells cultured with Ag plus anti+ to the pfc values 
forcellscultured with Agplusanti-Ek(calculated asdescribed in Experi- 
mental Procedures). 
(B) CHlB.LX (none refers to the lack of A$ expression by CHlPLX, 
so the A&‘-specific MAb does not signal), wild-type bb, 6CT1, bCT2, 
6CT4, 6CT5, 6CT6, and 6CT7 transfectants were incubated with Ag 
(SRBC) alone (background values of <5%, which are subtracted prior 
to calculation of ratios) or Ag plus MAbs specific for endogenous Ek 
or transfected ABb molecules. pfcs were determined and the ratio of 
pfc to Ah/EL was calculated as described in Experimental Procedures. 
Values are the mean ratios determined from 3-4 individual subclones. 
Bishop (1993) and an example is shown in Figure 2A, in 
which three individual transfectants bearing the mutant 
f3CT6 (discussed below) are analyzed. It can be seen that, 
although absolute numbers of IgM-secreting cells (plaque- 
forming cells [pfc]) differ for each transfectant, signaling 
induced via the f3CT6 molecule compared with signaling 
induced via the endogenous E molecule (Figure 2A, ratios 
shown above cross-hatched bars) is similar between cell 
lines. 
fSS?ific Class II Domains Deliver Distinct Signals to B Cells 
In the mutant 8CT2 (see Figure lA), G227 and P228 
were replaced in their wild-type positions. 6CT2 was able 
to signal at approximately 70%~ of wild-type levels (Figure 
26) indicating that G227 and P228 are crucial to signaling 
function. Having demonstrated with the 8CT2 mutant that 
G227 and P228 were sufficient to restore class Il-medi- 
ated signaling significantly, the ability of either G227 or 
P228 alone to mediate these effects was examined. The 
mutants 6CT5, which replaces only P228, and 8CT8, 
which replaces only G227 (see Figure 1 A), do not signal 
above the level seen in 8CTl (Figure 2B). This demon- 
strates that neither G227 nor P228 alone is sufficient to 
restore signaling, and further suggests that the require- 
ment for G at this position may be very stringent. To exam- 
ine further the requirement for specific amino acids at posi- 
tions 227 and 228, point mutants were selected from a 
library of point mutants (see Experimental Procedures) in 
the 8 aa truncated CY domain (AlO). Two of these mu- 
tants, G227V and P228R, both show decreased signaling 
when compared with the wild-type Apb molecule, providing 
further evidence that G and P are specifically required at 
these positions. However, mutation to a residue found in 
human E8 and DP8 CY domains (P228Q) allows wild-type 
levels of signaling (see Figures 1A and 4A). 
That G227 and P228 in 8CT2 are necessary and suffi- 
cient to restore the majority of the wild-type signal sug- 
gests that these residues may interact with an associated 
protein in a specific fashion. One possible type of interac- 
tion is a pocket, which can accomodate the fairly bulky P 
at position 228 provided that position 227 is not occupied 
by a residue more bulky than G. An interaction of this sort 
might impose positional dependence upon G and P. To 
address this possibility, we constructed 6CT4 (see Figure 
1 A), which moves G and P together to a more membrane- 
proximal position. This molecule gives poor signals(Figure 
2B), comparable to mutants lacking a CY domain (A18) 
and replacement mutants lacking G, P, or both (8CT1, 
6CT5, and 8CT6). These results suggest that the position 
of G and P within the minimal length cytoplasmic tail is 
important for their ability to interact with intracellular sig- 
naling molecules. An additional construct, j3CT7 (see Fig- 
ure lA), which contains G and P preceded by only the 
arginine anchor is also defective in mediating differentia- 
tive signals in CH12.LX (Figure 28). Together, the data 
from these two mutants demonstrate that the function of 
G and P is dependent upon their position in the CY domain 
of AD. 
Glycine 227 and Proline 228 Are Sufficient for 
AB-Mediated Increases in Intracellular CAMP 
following Class II Ligation 
Previous studies demonstrate that class II-mediated sig- 
nals to B cells are associated with elevated intracellular 
CAMP (Cambier et al., 1987; Takahama et al., 1989; 
Bishop, 1991), that inhibition of CAMP production inhibits 
class II-mediated signaling (Takahama et al., 1989; Bi- 
shop, 1991), and that the CAMP analog, dibutryl-cyclic- 
AMP (dbcAMP), can partially or totally mimic class II- 
mediated signals (depending upon the assay used to 
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Figure 3. Class II-Mediated Generation of Intracellular CAMP in 
CHlP.LX Cells Expressing wild-type A$ or CY Domain Mutants 
(A) CHlP.LX, wild-type Arb (ABBl), ABBAlO, ABBAl3, fXT1, and 
f3CTP transfectants were stimulated with Ag plus MAbs specific for 
endogenous Ek or transfected Arb molecules, and CAMP was extracted 
and measured as described in Experimental Procedures. The ratio of 
CAMP to AVE* is given above each set of bars, and was calculated 
and normalized by dividing the pmol CAMP/~ x 105 cells following 
stimulation with Ag plus anti-A, MAb (striped bars) by the pmol CAMP/ 
2 x IO5 cells following stimulation with Ag plus anti-EL MAb (closed 
bars). CAMP values for cultures containing Ag alone (open bars) were 
subtracted from all values prior to the determination of ratios. 
(B) Direct comparison of ratios of CAMP production, calculated as for 
(A), from a separate experiment. 
measure signaling) (Cambier et al., 1987; Bishop, 1991; 
St. Pierre and Watts, 1991; Nabavi et al., 1992). Thus, we 
predicted that the CY domain of AB is required for the 
generation of the CAMP response. To test this prediction, 
we examined the ability of A molecules containing various 
mutations in the CY domain to deliver signals resulting in 
increased CAMP. Figure 3A shows that the minimal length 
CY domain capable of delivering wild-type signals as mea- 
sured by induced IgM secretion (AlO) is also sufficient 
for optimal CAMP generation. As for pfc assays, CAMP 
induction is measured for each transfectant by signaling 
through hb compared with Ek; ratios are shown above 
bars and in Figure 38. Removal of the entire CY domain 
abolishes CAMP generation in response to class II ligation 
(A18). However, the restoration of only G227 and P228 
is sufficient to restore CAMP generation to levels indistin- 
guishable from that induced via wild-type ABb (j3CT2). This 
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Figure 4. Induction of B Cell Differentiation and CAMP Generation via 
CY Domain Point Mutants of ABb 
(A) pfc response of the mutants G227V, P228R, and P2280 compared 
with CHlP.LX and ABBl. pfc ratios were determined as described for 
Figure 2; at least two independent subclones were tested for each 
mutant. 
(6) CAMP induction via signaling through wild-type and point mutants 
of AaD. CAMP ratios were determined as described in Figure 3. 
suggests that these residues either directly or indirectly 
interact with other proteins needed to increase intracellu- 
lar CAMP. The repositioning, removal, or replacement of 
G227 and P228 (except for the allowable substitution of 
the Q residue at position 228) results in an inability to 
generate intracellular CAMP (Figures 3 and 48) which cor- 
relates with the inability to deliver differentiative signals 
as determined by induction of IgM secretion (see Figures 
1 A, 2,4A). The requirement forGP/Q in the correct position 
reinforces the close correlation between CAMP generation 
and induction of IgM secretion following class II signaling. 
The Transmembrane Domain of A&’ Is Important for 
Class II-Mediated Differentiative Signals 
Previously, we reported that a modest but consistent level 
of signaling was detectable following complete removal 
of the CY domain of AB (Harton and Bishop, 1993; see 
Figure lA), although this molecule (ABBA18) was unable 
to generate elevated intracellular CAMP (see Figure 3). 
This finding suggested the involvement of additional 8 
chain domains in class II signaling. Consistent with this 
hypothesis, addition of dbcAMP in the presence of anti- 
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Figure 5. Class II-Mediated Signaling via TM Domain Mutants of Ash 
(A) CHiP.LX (none), wild-type bb, and &TM. transfectants (8TMa.l 
and 8TMa2) were stimulated with Ag plus MAbs specific for endoge- 
nous Ekor transfected A$ molecules, and the ratio of Pfc to Ab/Ek was 
calculated as described for Figure 2. 
(6) pfc values for three individual experiments performed on the sub- 
clone 8TMa.2. Experiments were performed and ratios (values above 
cross-hatched bars) were calculated as for Figure 2A. 
gen, without direct ligation of class II, is insufficient to 
mimic differentiation signals delivered via wild-type class 
II (Bishop, 1991). However, near complete restoration of 
signaling was observed in the Al8 mutant if class II was 
cross-linked in the presence of dbcAMP (Figure 5A, dis- 
cussed below). Taken together, these observations 
strongly suggested that ligation of class II affects not only 
CY domain signaling, but that other regions of the class 
II molecule are important to the signal. To determine 
whether this contribution is dependent upon the TM do- 
main of A8, we examined signaling via mutant A8 mole- 
cules in which the TM domain of 8 was replaced with that 
of a (AoTM,; see Figure 1B). The TM domain of a was 
chosen to replace 8, as it was previously demonstrated 
that a TM domains successfully interact and bind to each 
other (Cosson and Bonifacino, 1992). Although membrane 
expression of this molecule was equal to that of wild-type 
Ar? transfectants (data not shown), and the molecule con- 
tains a wild-type CY domain, induced differentiation via 
ArTM,was markedly decreased (Figure 5). The substantial 
loss of function with this mutant (an 80%-85% decrease) 
demonstrates that the TM domain of the 8 chain is mediat- 
ing a function crucial to signaling. 
Specific Class II Domains Deliver Distinct Signals to B Cells 
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Figure 6. Enhancement by dbcAMP of Class II-Mediated Signals 
Generated by CY Domain Mutants of ABD 
CHlZ.LX (none), wild-type Aob, ABBAIO, All, 812. A17, A18 (A) or 
6CT1,6CTP, 6CT5,6CT6, and 6CT7 (6) transfectants were stimulated 
with Ag plus MAbs specific for endogenous EL or transfected Arb mole- 
cules as in Figure 2, in the presence (hatched bars) or absence (solid 
bars) of the CAMP analog dbcAMP. The ratio of pfc to AVE’; was calcu- 
lated as described for Figure 2. Data are representative of two experi- 
ments, which gave similar results. 
Direct Elevation of Intracellular CAMP Increases 
Signaling in Transfectants Expressing CY 
Domain Mutants of ABb 
Because signaling-defective mutants of the A0 CY domain 
could not function in either MHC class II-mediated differ- 
entiation or CAMP elevation, it was of interest to determine 
whether elevating intracellular CAMP directly, together 
with class II engagement, could restore signaling in these 
mutants. Individual representative subclones expressing 
wild-type or CY mutant ABb molecules were cultured with 
antigen and ABb-specific monoclonal antibodies (MAbs), 
with or without dbcAMP. Inclusion of dbcAMP significantly 
increased the effectiveness of signals in cells expressing 
signal-deficient class II molecules with CY domain muta- 
tions (Figure 6). Results shown for CH12.W (bars labeled 
none) demonstrate, as reported previously (Bishop, 1991) 
that dbcAMP plus Ag alone, without class II engagement, 
stimulates only a modest amount of differentiation (2- to 
3-fold above background). This amount is lo- to 50-fold 
lower than differentiation induced by anti-class II plus Ag. 
dbcAMP does not enhance signaling through endogenous 
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Figure 7. Mutation of the 6 Chain TM Domain Does Not Affect Class 
II-Mediated CAMP Generation 
(A) Class h-mediated generation of intracellular CAMP in CHlP.LX 
cells expressing wild-type A8 or CY @CT5 and 6CT7) or TM (6TMa) 
domain mutants. Cells were stimulated with Ag plus EL or Ab-specific 
MAbs, and CAMP quantitated as for Figure 3. 
(B) A representative transfectant expressing the CY domain mutant 
6CT7 and two transfectants expressing the ABTM. mutant were cul- 
tured with Ag plus EL or AQpecific MAbs, plus or minus dbcAMP, as 
in Figure 6. pfc/ld viable recovered cells were determined as de- 
scribed in Experimental Procedures. Open bars, EQpecific MAb; 
closed bars, AD-specific Mab; cross-hatched bars, AD-specific MAb plus 
dbcAMP. Results are mean f SEM of triplicate cultures, and are 
representative of two similar experiments. 
Ek molecules (Bishop, 1991) or in transfected ABb wild-type 
or ABBAlO (Figure 6A). Consistent with the observation 
that CAMP generation is maximal in cells transfected with 
6CT2, the addition of dbcAMP had no detectable effect on 
class II-mediated differentiative events in 8CT2 mutants 
(Figure 6B). This further supports our conclusion that the 
major requirement of the CAMP pathway is G227 and 
P/Q228 in the appropriate location. In transfectants ex- 
pressing mutant Ar,b molecules that showed severely im- 
paired signaling, however (All, A12, A17, A18, 6CT1, 
pCT4, 6CT5, 8CT6, 8CT7), the combination of dbcAMP 
and ligation of Apb increased signaling to approximately 
80% of that seen via endogenous Ek (cross-hatched bars). 
The TM Domain-Mediated Signal Is Distinct from 
the CY Domain-Mediated CAMP Response 
To test the possibility that changes in the TM domain af- 
fected the ability of the molecule to generate CAMP fol- 
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lowing class II engagement, CAMP generation in cells 
expressing ArTM, was investigated. Ligation of A,TM, 
molecules led to an increase in intracellular CAMP compa- 
rable to that seen with engagement of wild-type A$’ mole- 
cules (Figure 7A). This result contrasts with the lack of 
class II-mediated CAMP elevation seen in the signaling- 
defective CY domain mutants 8CT5 and 8CT7. Consistent 
with this finding, addition of dbcAMP did not rescue the 
defective signaling seen in ApTM. mutants, as it did in CY 
domain mutants (Figure 78). Thus, signals generated via 
the TM domain are independent of events leading to CAMP 
generation, indicating that signaling via the CY and TM 
domains of class II use distinct pathways. These pathways 
must be at least partially cooperative, however, as disrup- 
tion of either leads to loss of the majority of class II- 
induced B cell differentiation. 
Discussion 
There is an increasing body of data supporting the role 
of MHC class II molecules as signal receptors for B lym- 
phocytes (recently reviewed by Scholl and Geha, 1994). 
A number of early events (Bishop, 1991; St. Pierre and 
Watts, 1991; Fuleihan et al., 1992; Newell et al., 1993; 
Marshall et al., 1994) as well as more distal effects (Pala- 
cios et al., 1983; Bishop and Haughton, 1986; Wade et 
al., 1989; Hamano et al., 1990; Bishop et al., 1993; Newell 
et al., 1993; Truman et al., 1994) have been described 
following engagement of class II molecules. The role of 
the 8 chain of the class II a8 heterodimer has received 
the greatest attention, as several studies suggest the pre- 
dominance of the 8 chain in signaling events (Bishop and 
Frelinger, 1989; Wade et al., 1989). Truncation of the CY 
domain of the a chain also appears to affect successful 
antigen presentation to certain T cell clones (Wade et al., 
1994), but whether or not this effect involves signal trans- 
duction via class II is unknown. The present study focuses 
on a defined region of the class II A0 CY domain involved 
in signal transduction, and also demonstrates an im- 
portant role for the TM domain of AB in class II signaling. 
We extend our previous structure/function analyses by 
demonstrating that within the eight membrane-proximal 
residues of the CY domain of AP necessary and sufficient 
for class II-mediated differentiative signaling, the residues 
at positions 227 and 228, independent of specific residues 
at positions 221-226, are sufficient for a substantial por- 
tion of class II-mediated differentiative signals. Addition- 
ally, when in the appropriate position, these residues are 
sufficient to mediate class II-induced intracellular CAMP 
responses, demonstrating that a major signaling function 
of the CY domain of AB is the generation of a CAMP re- 
sponse. This conclusion is consistent with the observa- 
tions of others that CAMP analogs restore certain class 
II-mediated signals to truncated class II molecules, such 
as successful antigen presentation and translocation of a 
CAMP-dependent kinase (Nabavi et al., 1989; Wade et al., 
1989; St. Pierre and Watts, 1991). 
The induction of CAMP following ligation of MHC class 
II molecules on mouse B cells has been demonstrated 
previously (Cambier et al., 1987; Takahama et al., 1989; 
Bishop, 1991; Newell et al., 1993). The class II-mediated 
CAMP response appears to be important for the induction 
of PKC translocation to the nucleus (Cambier et al., 1987) 
the induction of apoptosis in naive resting B cells (Newell 
et al., 1993) the ability of anti-class II MAbs to inhibit lipo- 
polysaccharide or T cell-derived growth factor-stimulated 
proliferation of B cells (Takahama et al., 1989) and the 
stimulation of class II-mediated antigen-dependent differ- 
entiation in CH12.LX (Bishop, 1991). Our results demon- 
strate that the observed CAMP dependency of these 
events may be attributed to the function of specific resi- 
dues in the cytoplasmic domain of the Ar chain. 
The function of G227 and P228 is position dependent 
and likely requires G and P/Q specifically, as changes at 
these positions @CT5 8CT6, G227V, and P228R) nearly 
abrogate both differentiative signaling as well as intracellu- 
lar CAMP generation. Data showing that 8CT5 and 8CT6 
have a more drastic loss of function while still possessing 
either G227 or P228 alone suggest that the requirement 
for G and P is stringent, and further suggests the possibility 
that residual signaling observed with the point mutants is 
due to the presence of the wild-type residues in positions 
220-226. This is also consistent with the observation that 
pCT2 only restores 70% of the wild-type signal, suggesting 
that residues 220-226 are required for optimal signaling. 
These data are consistent with the possibility that the CY 
domain of Ar, and specifically G227 and P228, interacts 
with proteins that ultimately activate a G protein; this, in 
turn, can activate adenylate cyclase and leads to in- 
creased CAMP. However, our data do not establish that 
these residues themselves are crucial for protein-protein 
contact; they may instead assure that the proper confor- 
mation for such contact is maintained. 
G227 is absolutely conserved in A and E molecules and 
is generally conserved in HLA-D gene products. P228 is 
absolutely conserved in A molecules, while in E molecules, 
glutamine is substituted for P at position 228. In HLA-D 
gene products, this position contains either glutamine (Cl) 
or histidine (H) (Harton and Bishop, 1993). We speculate 
that position 228 may function as a specific interaction 
site for a signaling protein or for an adapter molecule. 
There is recent precedence for this type of interaction, as 
proline is reported to be an important residue in certain 
class I peptide-binding motifs (Sidney et al., 1995). Q (in 
mouse E molecules and HLA-DP) effectively substitutes 
for P (Figures 1 and 4). This is not entirely surprising, as 
HLA-D molecules are capable of mediating increases in 
intracellular CAMP (J. A. H. and G. A. B., unpublished 
data). Although the wild-type CY domain of AB is proline 
rich, an interaction with an SH3 domain requiring only a 
single P residue (as in the case of 6CT2), or no P residues 
(I-E and HLA-D), seems unlikely. G227 may function sim- 
ply as a spacer, allowing P228 to be accessible to an asso- 
ciated protein via free rotation at this position, aschanging 
this residue to an alanine @CTl), which may lead to repul- 
sion by hydrophobic residues, abrogates function. 
Addition of dbcAMP substantially complements differ- 
entiative signaling via AB molecules with detrimental muta- 
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tions in their CY domains. This supports the conclusion 
that mutations in the CY domain of Ab that affect signaling 
act primarily by disrupting the generation of CAMP. The 
simplest explanation of these results is that only the CAMP 
pathway is affected by alteration of the CY domain of Ap. 
Although this hypothesis is consistent with the data, addi- 
tional effects cannot be excluded. 
We also report here a direct demonstration that the TM 
domain of AB is important to class II-mediated B cell signal- 
ing. Addition of dbcAMP in the presence of antigen, with- 
out class II ligation, results in a minimal differentiative re- 
sponse, suggesting that increases in CAMP mediated by 
the CY domain of AP are insufficient for complete signaling. 
Thus, we predicted the existence of another signaling 
pathway. This was further supported by our previous ob- 
servation that a small but clearly demonstrable and con- 
sistent differentiative signal occurs in cells expressing 
ABBA18 (complete removal of the CY domain of AP) follow- 
ing class II engagement. To test the possible involvement 
of the TM domain, we replaced the TM domain of Ar, with 
that of A, (Ar,TM,; Figure 1 B). The ABTM, mutant signals 
poorly (only 10%-200/o of wild type), demonstrating that 
this domain is required for wild-type signal transmission. 
The potential effects of altered TM domains on the expres- 
sion, pairing, and conformation of class II molecules was 
considered before designing the ArTM, molecule. Cosson 
and Bonifacino (1992) demonstrated that substitution of 
class II TM domains with those of Tat antigen abrogates 
surface expression and alters the conformation of the 
class II external domains. Others have shown that 
changes in the extracellular domains of class II, which 
alter binding of conformation-sensitive MAbs, are detri- 
mental to pairing, surface expression, or both (Braunstein 
and Germain, 1987; Buerstedde et al., 1988). Replace- 
ment of the TM domain of AB with that of A,, requires dimer- 
ization of A, domains for pairing and surface expression. 
The study of Cosson and Bonifacino (1992) predicts that 
this combination will be successful, because their model 
suggests direct interactions of glycine-rich TM interfaces 
are important for successful heterodimerization and cor- 
rect conformation. The a TM domain provides glycine in- 
terfaces predicted for 8, and maintains the apposition of 
a G and a Fat two serial interface positions in the carboxyl 
portion of the heterodimericTM domain (Cosson and Boni- 
facino, 1992; unpublished data). Consistent with these 
predictions, transfectants of CH12.LX express ABTM, mol- 
ecules on the surface at levels similar to other transfected 
Ar molecules, suggesting no major pairing or conforma- 
tional changes. The possibility of minor conformational 
alterations cannot be entirely excluded, as conformation- 
sensitive Ab-specific MAbs have not been reported. 
The generation of CAMP following ligation of ABTM, was 
equivalent to that for wild-type class II molecules, indicat- 
ing that the A,TM, molecule is not unable to deliver signals. 
In addition, these data show that the TM signal is distinct 
from the CY domain-dependent CAMP response. As pre- 
dicted, addition of dbcAMP did not detectably enhance 
signaling through ABTM,. This suggests that other associ- 
ated proteins, separate from those interacting with the CY 
domain, are mediating crucial aspects of class II signaling, 
and that the MHC class II molecule is likely part of a multi- 
protein signaling complex, as is true of membrane immu- 
noglobulin and the T cell receptor. 
Morio et al. (1994) have demonstrated the involvement 
of the src-kinase family members lyn and fgr in staphylo- 
coccal superantigeninduced class II signaling in the hu- 
man B lymphoma line Raji. PTK activation has also been 
described following superantigen engagement of class II 
molecules on human monocytes (Matsuyama et al., 1993; 
Morio et al., 1994). Our results demonstrating a signaling 
pathway involved in B cell differentiation distinct from the 
CAMP pathway are consistent with the involvement of a 
PTK. It is possible that signals transmitted by the TM do- 
main are linked to one or more PTKs, as phosphotyrosine 
containing proteins have been detected in the B cell line 
K46 following class II ligation even in the absence of class 
II CY domains (Andre et al., 1994). We have recently ob- 
served that differentiative signaling by wild-type class II 
molecules is inhibited by the PTK inhibitor herbimycin A 
when added together with anti-class II MAb 18 hr after 
addition of antigen. This treatment abolished the residual 
signal observed with the CY domain mutant ABBAl8 but 
did not further decrease signaling in the TM domain mu- 
tant AoTM,, which has a wild-type CY domain (data not 
shown). These data are consistent with the hypothesis that 
the TM domain of AP is involved in activating a PTK. 
A summary of class II signaling events affected by struc- 
tural alterations in either the CY or TM domain is shown 
in Table 1. AB chains, which contain at least eight mem- 
brane-proximal amino acids, including G227 and P228, 
show wild-type levels of signaling as measured by CAMP 
elevation and induction of immunoglobulin secretion. Al- 
teration or removal of either G227 or P/Q228 results in 
loss of both these measures of signaling. Differentiation 
can be restored by addition of the CAMP analog dbcAMP, 
but dbcAMP does not further elevate immunoglobulin se- 
cretion via ABb molecules that already induce effective acti- 
vation, such as ABBAlO and 8CT2. Alteration of the TM 
domain of A0 also results in loss of class II-mediated immu- 
noglobulin secretion, but CAMP elevation remains intact, 
and dbcAMP does not complement the signaling defect. 
Table 1. Summary of Structure-Function Requirements of CY and 
TM Class II Signaling 
CY domain’ TM domair? tcAMP” tPfcd dbcAMP-tPfc’ 
+ + + + - 
+ - + 
+ - + - 
‘Class II f3 chain CY domain consisting of at least 8 membrane- 
proximal amino acids, including G” and P or C? (wild type, ABBAIO, 
PCTP, and P228Q). 
’ Wild-type f3 chain TM domain amino acid sequence. 
’ Engagement of class II results in elevation of intracellular CAMP. 
’ Engagement of class II in the presence of Ag results in induction of 
Ag-specific IgM secretion, measured as direct pfc. 
* Addition of dbcAMP substantially increases Ag plus anti-class II- 
mediated IgM secretion, measured as direct pfc. 
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Experimental Procedures 
Construction of Truncation Mutants 
The CY domain truncation mutants of A$ (AIO, Al 1, A12, A17, 818) 
and the replacement mutant BCTl (Figure 1) have been described 
previously (Harton and Bishop, 1993). Replacement mutants of the CY 
domain of Ap” (BCTP, BCT4, BCT5, BCT6, and PCT7) were generated by 
oligonucleotide-directed mutagenesis of the PCTl replacement mu- 
tant using the polymerase chain reaction (PCR; Perkin Elmer-Cetus, 
Norwalk, Connecticut) essentially as described (Harton and Bishop, 
1993). The A,TM. mutant was constructed with a combination of the 
megaprimer and overlap extension methods (Ho et al., 1989; Sarkar 
andSommer, 1990), using thefollowingstrategy. In brief, theupstream 
primer TMuCTb (ACCATCTTCATCATTCAAGGCCTGCGTCACAGGA- 
GTCAGAAAGGACCT) was designed to introduce 15 nt of the carboxy 
terminal portion of the Aab transmembrane coding sequence, and was 
used in conjunction with the downstream primer JH12 (AAGGTACC- 
GAGTCACTGCAGGAGCCCT) to amplify the CY domain from an AB 
cDNA. The product of this reaction was denatured and used as a 
megaprimer with the upstream primer CP~TMa (CAGTCTGAGTC- 
TGCCTGGAGCAAGACTGTGGTGTGTGCCCTGGGGTTGT) to amplify 
the TM domain coding sequence of the A.“-containing plasmid pKAB 
(Bishop and Frelinger, 1989). The amplification product of primers 
JHll (TGTGAATTCGAGATGGCTCTGCAGATC) and Dl97B+ (CAT- 
CTTGCTCCAGGCAGACTC) was used with wild-type A$ cDNA as 
template, yielding the external domains of bb. The products of these 
reaction were used in an overlap-extension reaction, as previously 
described (Ho et al., 1989). Following the final amplification reaction, 
the product was digested with EcoRl and Kpnl and cloned into these 
sites in the eukaryotic expression vector pcDL-SRa296 (Takebe et al., 
1988). For each replacement mutant, the membrane proximal arginine 
anchor was left intact, as we predicted that the loss of a charged 
residue at this position might permit the CY domain to remain in the 
hydrophobic core of the plasma membrane. The G - V, P - R, and 
P-Q mutations in the minimal length CY domain were obtained from 
a saturation point mutant library of the Al0 truncated bb sequence, 
The generation of this library will be described in detail elsewhere 
(A. E. V., J. A. H., and G. A. B.. unpublished data). 
DNA Sequencing 
Templates were prepared by alkaline lysis followed by purification on 
a Qiagen column (Studio City, California) according to the protocol of 
the manufacturer, or by miniprep as described (Maniatis et al.. 1982; 
Hockenbery et al., 1990). Sequencing was performed as per the fmol 
cycle sequencing protocol (Promega, Madison, Wisconsin), with minor 
modifications, and samples were eiectrophoresed as described (Har- 
ton and Bishop, 1993). All templates were sequenced at least twice 
to ensure accuracy. 
Cells 
CHlP.LX is a surface lak, u+, S’, CD5’ mouse B cell clone derived by 
single cell cloning of the CH12 lymphoma. The derivation and pheno- 
type of CHlP.LX have been previously described (Bishop and 
Haughton, 1986). The membrane and secreted immunoglobulin of 
CH12.LX is specific for the phosphatidyicholine moiety of sheep eryth- 
rocytes (SRBC) (Mercolino et al., 1986). Cells were maintained in RPM1 
1640 medium containing 10% heat-inactivated fetal calf serum, 300 
Kg/ml L-glutamine, and 0.01 mM 2-mercaptoethanoi (BCM). Transfec- 
tants were selected and maintained in BCM containing 400 pglml of 
G418 (Sigma, St. Louis, Missouri). 
MAbs 
The MAbs used in this study were 34-5-3s (anti-Apb,d,p) (Ozato et al., 
1982), and 14448 (anti-E.*) (Ozato et al., 1980). Ail MAbs were pre- 
pared as hybridoma tissue culture supernatants in our laboratory. im- 
munoglobuiin concentrations were determined by isotype-specific 
enzyme-linked immunosorbent assay, as described (Bishop and 
Haughton, 1987). 
Transfection and Determination of Surface Expression 
CHlP.LX ceils were transfected by electroporation as previously de- 
scribed (Bishop and Freiinger, 1989; Harton and Bishop, 1993) with 
10-20 pg of A+” DNA, and 4 pg of a plasmid containing the selectable 
marker gene for neoR, pSV2neo (Southern and Berg, 1982). Surface 
expression of the A,Ybb heterodimer was confirmed for subclones 
expressing each truncation mutant by indirect immunofluorescence 
with the MAb 34-5-38, followed by goat anti-mouse IgG-fluorescein 
isothiocyanate (Southern Biotechnology, Birmingham, Alabama). As 
a control, cells were stained with goat anti-mouse IgG-fluorescein 
isothiocyanate alone. This analysis was performed on an FACScan 
flow cytometer (Becton Dickinson, San Jose, California) using the 488 
nm line from an argon-ion laser. Subclones bearing mutated AB chains 
were selected for analysis only if they expressed those molecules at 
levels similar to those seen with transfected wild-type A$, as described 
in our previous study (Harton and Bishop, 1993). 
Assay for B Cell Differentiation 
Induced differentiation of CHlP.LX cells and transfectants was mea- 
sured essentially as described (Bishop, 1991). In brief, cells were cul- 
tured in 0.2 ml of BCM in 96-well flat-bottomed tissue culture plates 
at a final concentration of 1.5 x IO3 cells/well. Cultures containing 
antigen included a final concentration of 0.1% SRBC (Elmira Bioiogi- 
cals, Iowa City, Iowa). Cultures were incubated for 72 hr at 37OC in 
5% COP in air. All cultureswere performed in triplicate. Direct hemolytic 
pfc were measured as described (Cunningham and Szenberg, 1968) 
and any background plaque formation (<5%) was subtracted to correct 
for basal levels of IgM secretion. Signaling by CHlS.LX and transfec- 
tants is expressed in several of the figures as a ratio of the pfc value 
for cells cultured with Ag plus anti-A@ MAb divided by pfc value for 
cells cultured with Ag plus anti-EL MAb. (Neither Ag nor class II alone 
induces pfc in CHIPLX; both are required: Bishop and Haughton, 
1986). Thus, if signaling via transfected ApD is equal to signaling via 
endogenous EL, the ratio will be close to I. This is the case for signaling 
via wild-type A+“, as shown previously (Bishop and Frelinger, 1989; 
Harton and Bishop, 1993). For each transfectant, 3-4 individual clones 
were each tested several times. For those cultures containing the 
cAMPanalogdbcAMP(SigmaChemicai, St. Louis, Missouri), dbcAMP 
was added at a final concentration of 3.0 mM, a concentration pre- 
viously shown to be optimal for CHl2.W (Bishop, 1991). 
Cyclic AMP Radlolmmunoassays 
Intracellular CAMP was extracted from stimulated or unstimulated 
CHlP.LX and transfectants as previously described (Bishop, 1991). 
Intracellular CAMP concentrations were determined using a commer- 
cial RIA kit (NENIDuPont, Boston, Massachusetts) with modifications 
allowing for miniaturization (Berg and Hornbeck, 1993). Data are ex- 
pressed as the ratio of intracellular CAMP following ligation of wild-type 
or mutant ABE molecules/intracellular CAMP following ligation of the 
endogenous EL molecule. As shown previously (Bishop, 1991), and 
also shown in Figure 3A, we typically see background CAMP amounts 
of 2-10 pm0112 x 105celis, rising to 1 O-35 pmol/2 x 1O”celis following 
stimulation ofasignaiing-effective molecule. Fold stimulationsaretypi- 
caily 2- to 5-fold; if a positive control (anti-E) stimulation is less than 
2-fold, we do not consider this a successful stimulation, and do not 
attempt to calculate ratios from such data (the experiment would be 
redone). 
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